Chemotherapy-associated thromboembolic risk in cancer outpatients and effect of nadroparin thromboprophylaxis: results of a retrospective analysis of the PROTECHT study - Barni, S; Labianca, R; Agnelli, G (J Transl Med, 2011)
et al.